
How new technology can impact cardiac imaging in oncology clinical trials and have broader implications for patient safety.
How new technology can impact cardiac imaging in oncology clinical trials and have broader implications for patient safety.
Explore the growing interest in better understanding the potential for cardiovascular complications associated with cancer therapies.
Over the last decade, many initiatives sponsored by various entities, including academic and clinical research centers have focused on efforts to streamline clinical trial eligibility and data collection. Oncology trial design is no exception as endpoints and eligibility criteria have also changed with the value of the data generated in early phase studies.
The selection of study endpoints is one of many risks that a clinical research study can face. An independent review can help avert this by identifying potential issues within clinical trial data early in the study and allowing the study team to monitor, intervene and reduce study risks.
Progress and innovation within oncology has accelerated to a paradigm that includes immunotherapy and bio-genomics. Collaborative approaches in the future will continue to transform treatments in hopes of improving patient quality of life.
With significant technology advances in ECG recording through the years, the need to expand on traditional monitoring baselines-and include new variables such as time when designing clinical trial protocols-is important.
Published: February 13th 2025 | Updated: March 4th 2025
Published: February 19th 2025 | Updated: February 26th 2025
Published: March 24th 2023 | Updated:
Published: April 28th 2021 | Updated:
Published: July 26th 2024 | Updated:
Published: January 31st 2024 | Updated: